A physician colleague of mine discussed this yeste
Post# of 148279
He suggested, that were sufficient leronlimab available, every symptomatic patient, especially those with the major risk factors, would be receive it.
Keeping people out of the hospital (subq injection and go home) reduces the cost and burden on the health care system.
We won’t be there in the short term, but an appropriate long term approach (and lucrative for shareholders, BTW).